zur Navigation zum Inhalt
 
Onkologie 23. Jänner 2015

ASCO 2014: news, hopes, hypes?

This year’s American Society of Clinical Oncology (ASCO) saw some major improvements in the treatment of patients with solid tumors which, however, did not lead to a change in current clinical practice; at least not in the treatment of those solid tumors which will be reported within this summary. Surprisingly not all the therapeutic progress stems from targeted therapy but also from long-known substances like aromatase inhibitors. In total, more than 5000 abstracts have been presented at ASCO 2014. Within this review the most important abstracts covering head and neck tumors, breast cancer, melanoma, lung cancer, and colorectal cancer will be presented and put into context regarding actual clinical practice.

Zu diesem Thema wurden noch keine Kommentare abgegeben.

Mehr zum Thema

<< Seite 1 >>

Medizin heute

Aktuelle Printausgaben